Medical News

RSS

SPI-Bio to distribute and sell Aterovax's sPLA2 activity test in Europe

Aterovax SA, a company developing innovative products for atherosclerosis, today announced the signing of a 3 year, exclusive agreement with SPI-Bio, a specialist distributor of products and services in drug development, to distribute and sell Aterovax's sPLA2 activity test in Europe to academic and research laboratories for research use.

19 Apr 2010

Today's OpEds: Heritage disputes Obama's claims on health law; Florida nursing home reforms in danger

Think tank analysts usually brim with pride when the president of the United States goes around claiming that his policies are based on their work. But when President Obama tries to sell his health-care law as a moderate approach that borrows ideas developed by the Heritage Foundation, we get incensed (Robert Moffit, 4/19).

19 Apr 2010

Novartis withdraws EMA MAA for JOULFERON

Human Genome Sciences, Inc. today announced that Novartis has withdrawn a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for approval to market JOULFERON® (albinterferon alfa-2b, known in the United States as ZALBIN™) for the treatment of chronic hepatitis C.

19 Apr 2010

Generex Biotechnology announces plan to obtain cost reimbursement coverage for Generex Oal-lyn

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has established an action plan for obtaining cost reimbursement coverage for Generex Oal-lyn™, including the development of an insurance product that covers the costs of Generex Oral-lyn™ and any additional and/or comparable diabetes products.

19 Apr 2010

"Brain Port" surgery helps remove colloid cyst in 15-week pregnant woman

A unique device developed to make brain surgery easier and less traumatic has been successfully used on a patient who was pregnant and suffering from a potentially life-threatening brain cyst. The device, called a "Brain Port," was pioneered by renowned neurosurgeon Amin Kassam, MD, Medical Director of the Neuroscience Institute at Saint John's Health Center.

19 Apr 2010

Laparoscopic sleeve gastrectomy receives health insurance coverage

The American Society for Metabolic and Bariatric Surgery (ASMBS) today announced its support of recent policy changes by Aetna Inc. and United Healthcare. The national health insurance giants will now cover laparoscopic sleeve gastrectomy, a newer method of bariatric surgery that is becoming increasingly popular as a treatment for morbid obesity.

19 Apr 2010

Raloxifene, tamoxifen remain effective options in prevention of breast cancer, finds 19,490-patient study

In an update of the 19,490-patient Study of Tamoxifen and Raloxifene (STAR) P-2 trial in breast cancer prevention, both raloxifene and tamoxifen remain effective options to prevent breast cancer at 81 months of follow-up.

19 Apr 2010

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Joseph F. Finn, Jr., C.P.A., Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc., announced today that the MRI imaging intellectual properties will be auctioned on May 28, 2010. The assets of Epix were transferred to him on July 20, 2009 and he is liquidating them for the benefit of Epix creditors. He recently reached an agreement with Bayer Schering Pharma that permits the sale of the MRI imaging programs.

19 Apr 2010

Magen Medical Solutions announces successful implantation of SpineShield anti-adhesion device

Magen Medical Solutions Ltd., a medical device company developing unique anti-adhesion devices for orthopedic applications, is pleased to announce that it has successfully implanted its first product, the SpineShield, in three patients at a clinical site in Europe.

19 Apr 2010

NanoImaging Services receives grant to develop methods for characterization of nanoparticle morphology

NanoImaging Services, Inc., announced today that it has received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health through the National Center for Research Resources to develop new methods for quantitative characterization of nanoparticle morphology and aggregation state using transmission electron microscopy. The grant provides approximately $200,000 in research and development funds for a Phase I study.

19 Apr 2010

Jennerex presents positive interim data from Phase 2 clinical trial of JX-594 for HCC at 45th EASL

Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced the presentation of positive interim data from its randomized Phase 2 clinical trial using JX-594 for the treatment of advanced hepatocellular carcinoma (HCC), or liver cancer, at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL) in Vienna, Austria.

19 Apr 2010

Hospira enters definitive merger agreement to acquire Javelin Pharmaceuticals for $145M

Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and Javelin Pharmaceuticals, Inc., today announced that the companies have entered into a definitive merger agreement providing for the acquisition of Javelin by Hospira for $2.20 per share in cash, or approximately $145 million. Hospira expects to commence a tender offer for all outstanding shares of Javelin common stock on or about April 21, 2010, in accordance with the terms of the merger agreement.

19 Apr 2010

Rhythmlink International obtains Health Canada Medical Device License

As of April 13, 2010, Rhythmlink International has been granted its Health Canada Medical Device License and will now market and sell product in Canada. In accordance with the Medical Device Regulations, Section 36, of Health Canada's Therapeutic Products Directorate, Rhythmlink's Disposable Subdermal Needle Electrodes and EEG Electrodes both received individual licenses for their families of products.

19 Apr 2010

Dyadic International announces agreement to resolve consolidated stockholder class action lawsuit

Dyadic International, Inc. announced today an agreement to resolve the consolidated stockholder class action lawsuit against Dyadic and certain of its current and former officers and directors which was initially filed in October 2007.

19 Apr 2010

ConvaTec's Vitala Continence Control Device receives 2010 Medical Design Excellence Award

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that the Vitala™ Continence Control Device (CCD) has received a 2010 Medical Design Excellence Award.

19 Apr 2010

Myriad Pharmaceuticals terminates merger agreement with Javelin Pharmaceuticals

Myriad Pharmaceuticals, Inc. today announced the termination, effective as of Friday, April 16, 2010, of its merger agreement with Javelin Pharmaceuticals.

19 Apr 2010

BioMarin Pharmaceutical introduces Firdapse for LEMS in the E.U.

BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.

19 Apr 2010

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported the development of a novel protein complex, designated as E1-L-thP1, for targeted delivery of small interfering ribonucleic acids (siRNAs) to diverse solid cancers.

19 Apr 2010

Ingen Technologies provides update on Proxy vote and plans up-list onto OTCBB

Ingen Technologies, Inc., is an ISO Certified and FDA Registered medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company sells their patented and proprietary Oxyview and SMART Nasal Cannula along with their most recent released INGEN Pulse Oximeter. Today the company announced Proxy results and growth plans.

19 Apr 2010

Affinion Security Center enhances BreachShield service

Affinion Security Center, a leading provider of identity theft protection services, today announced enhancements to its BreachShield(SM) service, aimed at preventing, detecting and resolving Identity Theft resulting from data breaches for companies at risk and the consumers who trust those organizations. The new enhancements are designed for all types of organizations that experience a breach and include benefits that help customers at risk for medical identity theft.

19 Apr 2010

Medical News

SPI-Bio to distribute and sell Aterovax's sPLA2 activity test in Europe

Today's OpEds: Heritage disputes Obama's claims on health law; Florida nursing home reforms in danger

Novartis withdraws EMA MAA for JOULFERON

Generex Biotechnology announces plan to obtain cost reimbursement coverage for Generex Oal-lyn

"Brain Port" surgery helps remove colloid cyst in 15-week pregnant woman

Laparoscopic sleeve gastrectomy receives health insurance coverage

Raloxifene, tamoxifen remain effective options in prevention of breast cancer, finds 19,490-patient study

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Magen Medical Solutions announces successful implantation of SpineShield anti-adhesion device

NanoImaging Services receives grant to develop methods for characterization of nanoparticle morphology

Jennerex presents positive interim data from Phase 2 clinical trial of JX-594 for HCC at 45th EASL

Hospira enters definitive merger agreement to acquire Javelin Pharmaceuticals for $145M

Rhythmlink International obtains Health Canada Medical Device License

Dyadic International announces agreement to resolve consolidated stockholder class action lawsuit

ConvaTec's Vitala Continence Control Device receives 2010 Medical Design Excellence Award

Myriad Pharmaceuticals terminates merger agreement with Javelin Pharmaceuticals

BioMarin Pharmaceutical introduces Firdapse for LEMS in the E.U.

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Ingen Technologies provides update on Proxy vote and plans up-list onto OTCBB

Affinion Security Center enhances BreachShield service

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News